Mar 10, 2022 / 10:00PM GMT
Operator
Good day and thank you for standing by. Welcome to Q4 2021 Salarius Pharmaceuticals Earnings Webcast and Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. (Operator Instructions).
I would now like to hand the conference over to Jason Rando of Tiberend Strategic Advisors. Please go ahead.
Jason Rando - Tiberend Strategic Advisors - Executive Vice President & Chief Operating Officer
Good afternoon and thank you for joining Salarius Pharmaceuticals' 2021 fourth quarter and full year financial and corporate results call. This afternoon, Salarius Pharmaceuticals issued a press release detailing its financial results for the three months and full year ended December 31, 2021, which we encourage listeners to read. The press release can be found in the News section of salariuspharma.com.
Before beginning today's call, I would like to make the following statement.
Today, we will be making certain forward-looking statements about
Q4 2021 Salarius Pharmaceuticals Inc Earnings Call Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers